"IPO" Category

What’s An Energy Company CEO To Do?

Posted On September 14, 2015 | by Kristine Walczak

As energy stocks continue to slump and remain out of favor, many stories you’ll read will trumpet the doom and gloom of low share prices for energy companies and their investors. Right now, many energy stocks, particularly […]

Hype or Hush: The Pros and Cons of Going Public Part 3: Tick Size

Posted On June 24, 2015 | by Kristine Walczak

Today’s stock market is nearly transaction cost-free and overrun by trading schemes that can displace individual investors. While competition reduces trading costs for investors, it can have negative consequences for IPOs. Tick size, or the price increment […]

Hype or Hush: The Pros and Cons of Going Public Part 2: JOBS Act

Posted On May 27, 2015 | by Kristine Walczak

The IPO market continued its moderate pace in the first quarter of 2015, producing 28 IPOs. Of the 28 IPOs in 2015, return ranges from a loss of 32% of value to a return of almost 230%. […]

Hype or Hush: The Pros and Cons of Going Public

Posted On May 13, 2015 | by Kristine Walczak

Building on the momentum from 2013, the 2014 IPO market produced 244 IPOs, the highest annual figure since 2000 and almost one-third higher than the annual average of 186 IPOs recorded between 2004 and 2007—the last period […]

Restoring the Image of the Tainted Reverse Merger

Posted On December 15, 2014 | by AllenCaron

By guest author Nate Nead, Managing Director of www.reversemergers.comhttp://www.reversemergers.com/ http://www.reversemergers.com/ A recent conversation with a partner at a tier one law firm that regularly works on fully-underwritten IPOs went something like this. Me: “Tell me about your […]

Will Small Cap Wineries Ride the Wine Industry Wave?

Posted On August 22, 2014 | by AllenCaron

If you are looking for growth that’s oblivious to bull and bear markets, try the wine industry. Doesn’t the old adage say people drink in good times and bad? Statistics show that wine shipments in the U.S. […]

  If you have any acquaintance with the biotech and small pharma market,  you know who Dr Elemer Piros is.  Top-ranked by the Wall Street Journal and Financial Times in different years, he is with Burrill Securities […]

12

Subscribe to our RSS feed

Categories